A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(13 sites)
Belgium
UZ Antwerpen, Antwerp, Antwerp ULB Erasme, Brussels, Brussels Capital Cliniques Universitaires Saint-Luc UCL, Brussels, Brussels Capital CHC MontLégia, Liège, Liège AZ St-Lucas, Bruges, West-Vlaanderen Grand Hopital de Charleroi, Charleroi AZ Maria Middelares, Ghent University Hospital Ghent, Ghent Pôle Hospitalier Jolimont (HELORA), Haine-Saint-Paul Last updated February 2025